Thyroid storm is a life-threatening exacerbation of hyperthyroidism that requires urgent treatment. It is diagnosed using criteria from Burch and Wartofsky that evaluate temperature dysregulation, neurological changes, gastrointestinal involvement, cardiovascular dysfunction, and precipitating events. Treatment involves high dose thioamides to block hormone synthesis, inorganic iodides to block hormone release, beta-blockers to inhibit peripheral T4 to T3 conversion, and correcting homeostatic decompensation and any precipitating illnesses.
Thyroid storm is a life-threatening syndrome that results from an acute exacerbation of thyrotoxicosis. Prevention, prompt recognition, and appropriate intervention as discussed herein are key to the prevention of death and morbidity in affected patients. I hope you find it educating as well as enlightening.
This document discusses the management of thyroid storm, a life-threatening condition characterized by a hypermetabolic state caused by underlying hyperthyroidism. Key points include:
- Thyroid storm is diagnosed clinically or using scoring tools like the Burch-Wartofsky Point Scale.
- Management aims to inhibit thyroid hormone synthesis/release and peripheral effects while reversing decompensation. This involves high-dose antithyroid drugs, beta blockers, corticosteroids, inorganic iodide, and treating any precipitating factors.
- Supportive treatments like IV fluids and nutrition are also important, along with considering urgent thyroidectomy or radioactive iodine in some cases. Patient education is crucial
Thyroid storm is a life-threatening exacerbation of hyperthyroidism that can be fatal if not treated promptly and aggressively. It is usually precipitated by stress in individuals with poorly controlled hyperthyroidism. Signs and symptoms involve multiple organ systems and include fever, tachycardia, heart failure, gastrointestinal issues, and altered mental status. Treatment requires addressing the underlying hyperthyroidism with antithyroid drugs, iodine, beta-blockers, and glucocorticoids to suppress hormone production and effects. Managing precipitating factors, supportive care, and monitoring for complications are also important.
Thyroid storm is basically a life threatening acute exacerbation of the clinical features of thyrotoxicosis.
Thyroid storm also known as thyroid crisis is an acute, life threatening hypermetabolic state induced by excessive activity of thyroid hormones in individuals with thyrotoxicosis.
Exact pathogenesis not understood.
No clear cut clinical feature separation from thyrotoxicosis.
precipitants of thyroid storm include the following
Infection, especially pneumonia
Cerebrovascular accident
Acute coronary syndrome, Congestive heart failure
Pulmonary embolus
Diabetic ketoacidosis
Parturition / toxemia
Major trauma
Surgery
Iodine 131 Rx or iodine contrast agents
Rapid withdrawl of antithyroid medications
Although the exact pathogenesis of thyroid storm is not fully understood, the following theories have been proposed:
Patients with thyroid storm reportedly have relatively higher levels of free THs than patients with uncomplicated thyrotoxicosis, although total TH levels may not be increased.
Adrenergic receptor activation is another hypothesis. Sympathetic nerves innervate the thyroid gland, and catecholamines stimulate TH synthesis. In turn, increased THs increase the density of beta-adrenergic receptors, thereby enhancing the effect of catecholamines.
The dramatic response of thyroid storm to beta-blockers and the precipitation of thyroid storm after accidental ingestion of adrenergic drugs such as pseudoephedrine support this theory. This theory also explains normal or low plasma levels and urinary excretion rates of catecholamines.
However, it does not explain why beta-blockers fail to decrease TH levels in thyrotoxicosis.
Another theory suggests a rapid rise of hormone levels as the pathogenic source. A drop in binding protein levels, which may occur postoperatively, might cause a sudden rise in free hormone levels. In addition, hormone levels may rise rapidly when the gland is manipulated during surgery, during vigorous palpation during examination, or from damaged follicles following RAI therapy.
Other proposed theories include alterations in tissue tolerance to THs, the presence of a unique catecholaminelike substance in thyrotoxicosis, and a direct sympathomimetic effect of TH as a result of its structural similarity to catecholamines.
General symptoms
Fever
Profuse sweating
Poor feeding and weight loss
Respiratory distress
Fatigue (more common in older adolescents)
GI symptoms
Nausea and vomiting
Diarrhea
Abdominal pain
Jaundice
Neurologic symptoms
Anxiety (more common in older adolescents)
Altered behavior
Seizures, coma
The document discusses the thyroid gland and hypothyroidism. It provides details on the anatomy, histology, synthesis and secretion of thyroid hormones. It also describes the clinical features of hypothyroidism including constitutional symptoms like cold intolerance and fatigue. Laboratory tests for investigating thyroid function and disorders are outlined, including measurement of thyroid hormones and thyroid antibodies. Physical examination findings for the thyroid gland are also reviewed.
This document discusses hyperthyroidism and its treatment. It defines hyperthyroidism as increased secretion of thyroid hormones due to various stimuli. It then describes the clinical types of hyperthyroidism including diffuse toxic goitre (Graves' disease), toxic nodular goitre, and toxic nodule. The document outlines the symptoms, diagnosis, and principles of treatment for hyperthyroidism including anti-thyroid drugs, radioactive iodine therapy, and surgery. Treatment options depend on factors like the type and severity of hyperthyroidism, patient age and preferences.
This document discusses the case of a 56-year-old woman who presented with fever, sore throat, and breathlessness and was diagnosed with thyroid storm. It provides details on her medical history, examination, labs, and treatment. The document also discusses two additional cases of thyroid storm and provides a summary of key points on diagnosing and treating thyroid storm.
Thyroid storm is a life-threatening syndrome that results from an acute exacerbation of thyrotoxicosis. Prevention, prompt recognition, and appropriate intervention as discussed herein are key to the prevention of death and morbidity in affected patients. I hope you find it educating as well as enlightening.
This document discusses the management of thyroid storm, a life-threatening condition characterized by a hypermetabolic state caused by underlying hyperthyroidism. Key points include:
- Thyroid storm is diagnosed clinically or using scoring tools like the Burch-Wartofsky Point Scale.
- Management aims to inhibit thyroid hormone synthesis/release and peripheral effects while reversing decompensation. This involves high-dose antithyroid drugs, beta blockers, corticosteroids, inorganic iodide, and treating any precipitating factors.
- Supportive treatments like IV fluids and nutrition are also important, along with considering urgent thyroidectomy or radioactive iodine in some cases. Patient education is crucial
Thyroid storm is a life-threatening exacerbation of hyperthyroidism that can be fatal if not treated promptly and aggressively. It is usually precipitated by stress in individuals with poorly controlled hyperthyroidism. Signs and symptoms involve multiple organ systems and include fever, tachycardia, heart failure, gastrointestinal issues, and altered mental status. Treatment requires addressing the underlying hyperthyroidism with antithyroid drugs, iodine, beta-blockers, and glucocorticoids to suppress hormone production and effects. Managing precipitating factors, supportive care, and monitoring for complications are also important.
Thyroid storm is basically a life threatening acute exacerbation of the clinical features of thyrotoxicosis.
Thyroid storm also known as thyroid crisis is an acute, life threatening hypermetabolic state induced by excessive activity of thyroid hormones in individuals with thyrotoxicosis.
Exact pathogenesis not understood.
No clear cut clinical feature separation from thyrotoxicosis.
precipitants of thyroid storm include the following
Infection, especially pneumonia
Cerebrovascular accident
Acute coronary syndrome, Congestive heart failure
Pulmonary embolus
Diabetic ketoacidosis
Parturition / toxemia
Major trauma
Surgery
Iodine 131 Rx or iodine contrast agents
Rapid withdrawl of antithyroid medications
Although the exact pathogenesis of thyroid storm is not fully understood, the following theories have been proposed:
Patients with thyroid storm reportedly have relatively higher levels of free THs than patients with uncomplicated thyrotoxicosis, although total TH levels may not be increased.
Adrenergic receptor activation is another hypothesis. Sympathetic nerves innervate the thyroid gland, and catecholamines stimulate TH synthesis. In turn, increased THs increase the density of beta-adrenergic receptors, thereby enhancing the effect of catecholamines.
The dramatic response of thyroid storm to beta-blockers and the precipitation of thyroid storm after accidental ingestion of adrenergic drugs such as pseudoephedrine support this theory. This theory also explains normal or low plasma levels and urinary excretion rates of catecholamines.
However, it does not explain why beta-blockers fail to decrease TH levels in thyrotoxicosis.
Another theory suggests a rapid rise of hormone levels as the pathogenic source. A drop in binding protein levels, which may occur postoperatively, might cause a sudden rise in free hormone levels. In addition, hormone levels may rise rapidly when the gland is manipulated during surgery, during vigorous palpation during examination, or from damaged follicles following RAI therapy.
Other proposed theories include alterations in tissue tolerance to THs, the presence of a unique catecholaminelike substance in thyrotoxicosis, and a direct sympathomimetic effect of TH as a result of its structural similarity to catecholamines.
General symptoms
Fever
Profuse sweating
Poor feeding and weight loss
Respiratory distress
Fatigue (more common in older adolescents)
GI symptoms
Nausea and vomiting
Diarrhea
Abdominal pain
Jaundice
Neurologic symptoms
Anxiety (more common in older adolescents)
Altered behavior
Seizures, coma
The document discusses the thyroid gland and hypothyroidism. It provides details on the anatomy, histology, synthesis and secretion of thyroid hormones. It also describes the clinical features of hypothyroidism including constitutional symptoms like cold intolerance and fatigue. Laboratory tests for investigating thyroid function and disorders are outlined, including measurement of thyroid hormones and thyroid antibodies. Physical examination findings for the thyroid gland are also reviewed.
This document discusses hyperthyroidism and its treatment. It defines hyperthyroidism as increased secretion of thyroid hormones due to various stimuli. It then describes the clinical types of hyperthyroidism including diffuse toxic goitre (Graves' disease), toxic nodular goitre, and toxic nodule. The document outlines the symptoms, diagnosis, and principles of treatment for hyperthyroidism including anti-thyroid drugs, radioactive iodine therapy, and surgery. Treatment options depend on factors like the type and severity of hyperthyroidism, patient age and preferences.
This document discusses the case of a 56-year-old woman who presented with fever, sore throat, and breathlessness and was diagnosed with thyroid storm. It provides details on her medical history, examination, labs, and treatment. The document also discusses two additional cases of thyroid storm and provides a summary of key points on diagnosing and treating thyroid storm.
A complete presentation on hypothroidism endocrine disorder based on latest editon of harrison and reference books. this presentation will help to learn about this second most common endocrine disorder.
Thyrotoxicosis is a clinical syndrome caused by high levels of circulating thyroid hormones, with primary causes including Graves' disease and toxic nodular goiter, leading to symptoms of weight loss, fatigue, heat intolerance, and emotional changes. Diagnosis is based on examination findings of a goiter, tachycardia, and eye changes like exophthalmos, with treatment options including antithyroid drugs, radioactive iodine, or surgery to remove the overactive thyroid tissue.
This document discusses thyrotoxicosis, which results from excess thyroid hormone production regardless of cause. It is one of the more common endocrine disorders seen by family physicians. The causes of thyrotoxicosis include Graves' disease, toxic multinodular goiter, solitary toxic nodule, and thyroiditis. Graves' disease is an autoimmune condition characterized by a diffuse goiter, ophthalmopathy, and dermopathy. Toxic multinodular goiter develops from autonomy in a pre-existing nodular goiter. A solitary toxic nodule refers to autonomy developing in an otherwise normal thyroid. Thyroiditis can cause a transient thyrotoxic phase followed by hypothyroidism. Treatment depends on
Hypothyroidism can be primary, meaning it is caused by a problem in the thyroid gland itself, or secondary, caused by a lack of TSH from the pituitary gland. Primary causes include congenital defects, iodine deficiency, autoimmune disorders like Hashimoto's thyroiditis, and surgery or radiation treatment of the thyroid. Secondary hypothyroidism is caused by problems of the pituitary gland or peripheral resistance to thyroid hormone. Diagnosis is made through blood tests showing low T3 and T4 and high TSH for primary hypothyroidism. Treatment is lifelong thyroid hormone replacement, usually levothyroxine. Dosage depends on age, severity, and other factors.
This document discusses hyperthyroidism and Graves' disease. It provides details on:
- The causes of hyperthyroidism including circulating thyroid stimulators and thyroidal autonomy.
- The pathogenesis, clinical manifestations, and laboratory findings of Graves' disease. Common signs include diffuse goiter, ophthalmopathy, and localized dermopathy.
- The treatment options for hyperthyroidism including antithyroid drugs like methimazole, radioactive iodine, and surgery. Antithyroid drugs are usually the first line treatment.
The document describes several cases of thyrotoxicosis and discusses potential causes. It outlines cases of three patients, two children and one infant, who presented with thyrotoxicosis. The potential causes discussed include Graves' disease, toxic multinodular goiter, toxic adenoma, neonatal Graves' disease, activated TSH receptor, excess TSH, thyroiditis, and thyrotoxicosis resulting from excess iodine or medications like amiodarone.
A 27-year-old female presents with palpitations. Exam finds an enlarged, tender thyroid. Labs show suppressed TSH, elevated T4 and low radioactive iodine uptake. The next appropriate test would be to check the ESR, as these findings are consistent with subacute thyroiditis, an inflammation of the thyroid gland often caused by a viral infection. The treatment is symptomatic with pain medication as the condition will typically resolve on its own over several months.
Hypothyroidism is caused by an underactive thyroid gland that produces insufficient thyroid hormones. The document summarizes the symptoms, complications, classifications, and treatments for hypothyroidism. It provides details on the thyroid gland, hormones, and regulating system. Treatment recommendations include dietary changes like increasing iodine, calcium and magnesium intake. Herbal supplements like bladderwrack, oats and makandi are also suggested to support thyroid function.
Thyroid storm and myxedema coma are life-threatening emergencies caused by excess or deficiency of thyroid hormones respectively. Thyroid storm results from excessive thyroid hormones and causes hypermetabolism affecting multiple systems. Myxedema coma occurs in severe long-standing hypothyroidism when precipitated by an event and causes physiological decompensation. Both require rapid diagnosis and aggressive treatment in an ICU setting to prevent high mortality rates. Treatment involves supportive care, thyroid hormone replacement, glucocorticoids, and correcting underlying conditions.
This document discusses the diagnosis and management of pheochromocytoma. Key points include:
- Pheochromocytomas are rare catecholamine-secreting tumors that can cause hypertension. Diagnosis involves measuring plasma or urine metanephrines and imaging tests.
- Preoperative management aims to control blood pressure and prevent hypertensive crises during surgery. This involves alpha-blockade using drugs like phenoxybenzamine for 1-2 weeks before surgery.
- Surgery is the main treatment and involves an experienced multidisciplinary team. For inoperable or malignant tumors, nuclear medicine treatments or lifelong medical management may be used. Close postoperative monitoring is important.
The document discusses hypothyroidism, including its causes, signs and symptoms, diagnosis, and treatment. Some key points:
- Primary hypothyroidism is caused by failure of the thyroid gland and accounts for 99% of cases. Secondary hypothyroidism is caused by pituitary failure.
- Hashimoto's thyroiditis is the most common cause of hypothyroidism in iodine-sufficient areas. It is an autoimmune disorder more common in women.
- Diagnosis is based on elevated TSH and low free T4 levels. Treatment involves daily levothyroxine replacement therapy with dosages adjusted based on follow up TSH levels.
Thyroid disorders result from issues with thyroid hormone production or secretion, altering metabolism. Hyperthyroidism occurs when excessive thyroid hormones are produced, often due to Graves' disease, an autoimmune disorder. Hypothyroidism results from decreased thyroid hormone production, commonly caused by Hashimoto's thyroiditis or thyroid surgery/radiation treatment. Both conditions are managed through pharmacological interventions like antithyroid drugs or levothyroxine replacement therapy.
This document discusses hyperthyroidism, its causes, clinical manifestations, diagnosis, and treatment. The main causes discussed are Graves' disease, toxic multinodular goiter, and toxic adenomas. Graves' disease is an autoimmune disorder causing thyroid infiltration. Clinical manifestations include symptoms of hyperthyroidism as well as signs specific to Graves' such as ophthalmopathy. Diagnosis involves thyroid hormone blood tests. Treatment options include antithyroid medications, radioactive iodine therapy, and subtotal thyroidectomy. Congenital hyperthyroidism can occur when mothers pass antibodies to their infants and requires similar treatments.
Hypothyroidism is the failure of the thyroid gland to produce enough hormones. It can cause hypertension, dyslipidemia, infertility and other issues if untreated. It is most common in females and prevalence increases with age. Thyroid dysfunction is more common in diabetics than the general population. Screening is recommended for diabetics and those with risk factors like autoimmune disease or family history. A TSH test is used to diagnose, and levothyroxine replacement is the standard treatment, with dosage based on weight. Subclinical hypothyroidism may also be treated in high risk groups.
This document summarizes hypothyroidism and hyperthyroidism in the elderly. It discusses laboratory tests for thyroid function like TSH, T4, and T3. It describes signs and symptoms of hypothyroidism like fatigue, weight gain, and constipation. Physical exam findings in hypothyroidism include bradycardia, puffy features, and dry skin. Myxedema coma is a life-threatening complication of untreated hypothyroidism. Symptoms and signs of hyperthyroidism include weight loss, palpitations, and tremors. Physical exam may reveal lid lag, goiter, and tachycardia. Thyroid storm is a medical emergency caused by excessive thyroid hormone levels
1) Thyroid storm, or a thyrotoxic crisis, is a life-threatening exacerbation of hyperthyroidism caused by an abrupt release of thyroid hormones into circulation.
2) It presents with fever, tachycardia, arrhythmias, heart failure, tremors, and gastrointestinal issues like nausea and vomiting.
3) Treatment involves controlling adrenergic symptoms with beta blockers, treating the underlying thyroid abnormality with antithyroid drugs like PTU, and providing supportive care like fluids and electrolyte replacement.
The document discusses the relationship between thyroid disorders and cardiovascular disease. It covers how hyperthyroidism can cause tachycardia, arrhythmias, heart failure and pulmonary hypertension. Hypothyroidism is associated with bradycardia, hypertension and hyperlipidemia. Both conditions are linked to increased risk of atherosclerosis and heart disease. The document provides guidance on evaluation and treatment of thyroid disorders based on cardiovascular risk factors and comorbidities.
This document discusses hyperthyroidism and its management. It begins with definitions of hyperthyroidism and thyrotoxicosis. It then discusses the prevalence, anatomy, physiology and causes of hyperthyroidism. The clinical manifestations involving multiple body systems are explained in detail. Diagnostic tests including blood tests, ultrasound and radioactive iodine uptake scans are outlined. Finally, the medical management including antithyroid drugs, radioactive iodine therapy and surgery are summarized.
This document discusses thyrotoxicosis and hyperthyroidism. It begins by covering thyroid physiology including iodine metabolism and thyroid hormone synthesis. It then discusses the causes and clinical manifestations of Graves' disease (diffuse toxic goiter), toxic multinodular goiter, and toxic adenoma. Diagnostic tests and treatment options including antithyroid drugs, radioactive iodine therapy, and surgery are described for hyperthyroidism. Thyroid storm, a medical emergency, is also summarized.
This document provides an overview of thyroid function tests and their indications. It discusses the hypothalamic-pituitary-thyroid axis and the different thyroid hormones. Primary, secondary, and tertiary thyroid disorders are defined. The document outlines the mechanisms and patterns seen in non-thyroidal illness. It discusses the evaluation and interpretation of thyroid stimulating hormone, thyroid hormones, thyroid antibodies, and thyroglobulin levels. Approaches for discordant thyroid function test results are also summarized.
This document discusses thyroid dysfunction in critical care settings. It describes a case of a 61-year-old man admitted to the ICU for decompensated CHF who had an altered mental status and abnormal thyroid function tests. Specifically, his TSH was elevated at 13 while his free T4 was normal but T3 was low. This pattern is characteristic of non-thyroidal illness (NTI) or sick euthyroid syndrome, rather than primary hypothyroidism. The document then reviews thyroid physiology, deiodinases, alterations in thyroid hormones that occur in NTI versus primary or central hypothyroidism, and outcomes of thyroid hormone replacement studies in critical illness.
A complete presentation on hypothroidism endocrine disorder based on latest editon of harrison and reference books. this presentation will help to learn about this second most common endocrine disorder.
Thyrotoxicosis is a clinical syndrome caused by high levels of circulating thyroid hormones, with primary causes including Graves' disease and toxic nodular goiter, leading to symptoms of weight loss, fatigue, heat intolerance, and emotional changes. Diagnosis is based on examination findings of a goiter, tachycardia, and eye changes like exophthalmos, with treatment options including antithyroid drugs, radioactive iodine, or surgery to remove the overactive thyroid tissue.
This document discusses thyrotoxicosis, which results from excess thyroid hormone production regardless of cause. It is one of the more common endocrine disorders seen by family physicians. The causes of thyrotoxicosis include Graves' disease, toxic multinodular goiter, solitary toxic nodule, and thyroiditis. Graves' disease is an autoimmune condition characterized by a diffuse goiter, ophthalmopathy, and dermopathy. Toxic multinodular goiter develops from autonomy in a pre-existing nodular goiter. A solitary toxic nodule refers to autonomy developing in an otherwise normal thyroid. Thyroiditis can cause a transient thyrotoxic phase followed by hypothyroidism. Treatment depends on
Hypothyroidism can be primary, meaning it is caused by a problem in the thyroid gland itself, or secondary, caused by a lack of TSH from the pituitary gland. Primary causes include congenital defects, iodine deficiency, autoimmune disorders like Hashimoto's thyroiditis, and surgery or radiation treatment of the thyroid. Secondary hypothyroidism is caused by problems of the pituitary gland or peripheral resistance to thyroid hormone. Diagnosis is made through blood tests showing low T3 and T4 and high TSH for primary hypothyroidism. Treatment is lifelong thyroid hormone replacement, usually levothyroxine. Dosage depends on age, severity, and other factors.
This document discusses hyperthyroidism and Graves' disease. It provides details on:
- The causes of hyperthyroidism including circulating thyroid stimulators and thyroidal autonomy.
- The pathogenesis, clinical manifestations, and laboratory findings of Graves' disease. Common signs include diffuse goiter, ophthalmopathy, and localized dermopathy.
- The treatment options for hyperthyroidism including antithyroid drugs like methimazole, radioactive iodine, and surgery. Antithyroid drugs are usually the first line treatment.
The document describes several cases of thyrotoxicosis and discusses potential causes. It outlines cases of three patients, two children and one infant, who presented with thyrotoxicosis. The potential causes discussed include Graves' disease, toxic multinodular goiter, toxic adenoma, neonatal Graves' disease, activated TSH receptor, excess TSH, thyroiditis, and thyrotoxicosis resulting from excess iodine or medications like amiodarone.
A 27-year-old female presents with palpitations. Exam finds an enlarged, tender thyroid. Labs show suppressed TSH, elevated T4 and low radioactive iodine uptake. The next appropriate test would be to check the ESR, as these findings are consistent with subacute thyroiditis, an inflammation of the thyroid gland often caused by a viral infection. The treatment is symptomatic with pain medication as the condition will typically resolve on its own over several months.
Hypothyroidism is caused by an underactive thyroid gland that produces insufficient thyroid hormones. The document summarizes the symptoms, complications, classifications, and treatments for hypothyroidism. It provides details on the thyroid gland, hormones, and regulating system. Treatment recommendations include dietary changes like increasing iodine, calcium and magnesium intake. Herbal supplements like bladderwrack, oats and makandi are also suggested to support thyroid function.
Thyroid storm and myxedema coma are life-threatening emergencies caused by excess or deficiency of thyroid hormones respectively. Thyroid storm results from excessive thyroid hormones and causes hypermetabolism affecting multiple systems. Myxedema coma occurs in severe long-standing hypothyroidism when precipitated by an event and causes physiological decompensation. Both require rapid diagnosis and aggressive treatment in an ICU setting to prevent high mortality rates. Treatment involves supportive care, thyroid hormone replacement, glucocorticoids, and correcting underlying conditions.
This document discusses the diagnosis and management of pheochromocytoma. Key points include:
- Pheochromocytomas are rare catecholamine-secreting tumors that can cause hypertension. Diagnosis involves measuring plasma or urine metanephrines and imaging tests.
- Preoperative management aims to control blood pressure and prevent hypertensive crises during surgery. This involves alpha-blockade using drugs like phenoxybenzamine for 1-2 weeks before surgery.
- Surgery is the main treatment and involves an experienced multidisciplinary team. For inoperable or malignant tumors, nuclear medicine treatments or lifelong medical management may be used. Close postoperative monitoring is important.
The document discusses hypothyroidism, including its causes, signs and symptoms, diagnosis, and treatment. Some key points:
- Primary hypothyroidism is caused by failure of the thyroid gland and accounts for 99% of cases. Secondary hypothyroidism is caused by pituitary failure.
- Hashimoto's thyroiditis is the most common cause of hypothyroidism in iodine-sufficient areas. It is an autoimmune disorder more common in women.
- Diagnosis is based on elevated TSH and low free T4 levels. Treatment involves daily levothyroxine replacement therapy with dosages adjusted based on follow up TSH levels.
Thyroid disorders result from issues with thyroid hormone production or secretion, altering metabolism. Hyperthyroidism occurs when excessive thyroid hormones are produced, often due to Graves' disease, an autoimmune disorder. Hypothyroidism results from decreased thyroid hormone production, commonly caused by Hashimoto's thyroiditis or thyroid surgery/radiation treatment. Both conditions are managed through pharmacological interventions like antithyroid drugs or levothyroxine replacement therapy.
This document discusses hyperthyroidism, its causes, clinical manifestations, diagnosis, and treatment. The main causes discussed are Graves' disease, toxic multinodular goiter, and toxic adenomas. Graves' disease is an autoimmune disorder causing thyroid infiltration. Clinical manifestations include symptoms of hyperthyroidism as well as signs specific to Graves' such as ophthalmopathy. Diagnosis involves thyroid hormone blood tests. Treatment options include antithyroid medications, radioactive iodine therapy, and subtotal thyroidectomy. Congenital hyperthyroidism can occur when mothers pass antibodies to their infants and requires similar treatments.
Hypothyroidism is the failure of the thyroid gland to produce enough hormones. It can cause hypertension, dyslipidemia, infertility and other issues if untreated. It is most common in females and prevalence increases with age. Thyroid dysfunction is more common in diabetics than the general population. Screening is recommended for diabetics and those with risk factors like autoimmune disease or family history. A TSH test is used to diagnose, and levothyroxine replacement is the standard treatment, with dosage based on weight. Subclinical hypothyroidism may also be treated in high risk groups.
This document summarizes hypothyroidism and hyperthyroidism in the elderly. It discusses laboratory tests for thyroid function like TSH, T4, and T3. It describes signs and symptoms of hypothyroidism like fatigue, weight gain, and constipation. Physical exam findings in hypothyroidism include bradycardia, puffy features, and dry skin. Myxedema coma is a life-threatening complication of untreated hypothyroidism. Symptoms and signs of hyperthyroidism include weight loss, palpitations, and tremors. Physical exam may reveal lid lag, goiter, and tachycardia. Thyroid storm is a medical emergency caused by excessive thyroid hormone levels
1) Thyroid storm, or a thyrotoxic crisis, is a life-threatening exacerbation of hyperthyroidism caused by an abrupt release of thyroid hormones into circulation.
2) It presents with fever, tachycardia, arrhythmias, heart failure, tremors, and gastrointestinal issues like nausea and vomiting.
3) Treatment involves controlling adrenergic symptoms with beta blockers, treating the underlying thyroid abnormality with antithyroid drugs like PTU, and providing supportive care like fluids and electrolyte replacement.
The document discusses the relationship between thyroid disorders and cardiovascular disease. It covers how hyperthyroidism can cause tachycardia, arrhythmias, heart failure and pulmonary hypertension. Hypothyroidism is associated with bradycardia, hypertension and hyperlipidemia. Both conditions are linked to increased risk of atherosclerosis and heart disease. The document provides guidance on evaluation and treatment of thyroid disorders based on cardiovascular risk factors and comorbidities.
This document discusses hyperthyroidism and its management. It begins with definitions of hyperthyroidism and thyrotoxicosis. It then discusses the prevalence, anatomy, physiology and causes of hyperthyroidism. The clinical manifestations involving multiple body systems are explained in detail. Diagnostic tests including blood tests, ultrasound and radioactive iodine uptake scans are outlined. Finally, the medical management including antithyroid drugs, radioactive iodine therapy and surgery are summarized.
This document discusses thyrotoxicosis and hyperthyroidism. It begins by covering thyroid physiology including iodine metabolism and thyroid hormone synthesis. It then discusses the causes and clinical manifestations of Graves' disease (diffuse toxic goiter), toxic multinodular goiter, and toxic adenoma. Diagnostic tests and treatment options including antithyroid drugs, radioactive iodine therapy, and surgery are described for hyperthyroidism. Thyroid storm, a medical emergency, is also summarized.
This document provides an overview of thyroid function tests and their indications. It discusses the hypothalamic-pituitary-thyroid axis and the different thyroid hormones. Primary, secondary, and tertiary thyroid disorders are defined. The document outlines the mechanisms and patterns seen in non-thyroidal illness. It discusses the evaluation and interpretation of thyroid stimulating hormone, thyroid hormones, thyroid antibodies, and thyroglobulin levels. Approaches for discordant thyroid function test results are also summarized.
This document discusses thyroid dysfunction in critical care settings. It describes a case of a 61-year-old man admitted to the ICU for decompensated CHF who had an altered mental status and abnormal thyroid function tests. Specifically, his TSH was elevated at 13 while his free T4 was normal but T3 was low. This pattern is characteristic of non-thyroidal illness (NTI) or sick euthyroid syndrome, rather than primary hypothyroidism. The document then reviews thyroid physiology, deiodinases, alterations in thyroid hormones that occur in NTI versus primary or central hypothyroidism, and outcomes of thyroid hormone replacement studies in critical illness.
Thyroid storm, also known as thyrotoxic crisis, is a life-threatening complication of hyperthyroidism characterized by sudden multisystem involvement. It can occur in any diagnosed or undiagnosed case of hyperthyroidism. Thyroid storm is diagnosed clinically based on symptoms involving the central nervous, cardiovascular, gastrointestinal and hepatic systems. Treatment involves controlling adrenergic tone with beta-blockers, reducing thyroid hormone synthesis with thionamides, and blocking peripheral thyroid hormone conversion. Aggressive treatment is required for patients scoring above 45 on the Burch-Wartofsky Point Scale or meeting the criteria for definite or suspected thyroid storm per the Japanese Thyroid Association guidelines.
This document summarizes information about the thyroid gland and thyroid disorders. It describes the functions of thyroid hormones T3 and T4, the signs and symptoms of hyperthyroidism (thyrotoxicosis) and hypothyroidism, and the various causes of each condition. It also outlines the management and treatment approaches for hyperthyroidism and hypothyroidism, including anti-thyroid medications, radioactive iodine therapy, surgery, and levothyroxine replacement for hypothyroidism. Complications of treatment are also discussed.
The document summarizes key topics in endocrinology, including disorders of the thyroid, parathyroid, and adrenal glands. It discusses hypothyroidism and its causes, signs, symptoms, and treatment with levothyroxine replacement. It also covers thyrotoxicosis, hyperparathyroidism, Cushing's syndrome, and disorders of the adrenal cortex that can cause hormone deficiencies or excesses. The quiz at the end reviews topics like Cushing's syndrome and autoimmune destruction of pancreatic beta cells in type 1 diabetes.
This document discusses the diagnosis and management of primary hypothyroidism in a 32-year-old woman. She was found to have a very high TSH level of over 100 IU/ml and a low free T4, consistent with overt primary hypothyroidism. Further testing found she had a family history of hypothyroidism and goiter. She was diagnosed with postpartum thyroiditis, a common cause of transient hypothyroidism after delivery. Treatment involves thyroid hormone replacement with levothyroxine titrated based on follow-up TSH levels, with the goal of achieving a normal TSH level.
The next step is E) Continue to monitor patient and recheck thyroid function after illness resolve. This clinical presentation suggests Euthyroid Sick Syndrome/Non-thyroidal illness syndrome, which causes changes in thyroid function tests similar to hypothyroidism during acute illness but does not require thyroid hormone treatment. Thyroid function should be reassessed after recovery from the acute illness.
A 45-year-old male presented with weight loss, tremors, sweating, anxiety, insomnia, and increased appetite and bowel movements. Examination found tachycardia, proptosis, lid retraction, and a nodule in the right thyroid lobe. Investigations of thyroid function tests, ultrasound, scan, and uptake were recommended. A diagnosis of toxic adenoma (Plummer's disease) was made, where a single autonomous nodule in the thyroid causes hyperthyroidism. Treatment options included antithyroid drugs, radioactive iodine, or surgery. Complications discussed were hypothyroidism, thyroiditis, and rarely thyroid storm.
This document discusses thyroid function tests. It provides a classification of thyroid tests based on measuring hormone levels, thyroid function, metabolic effects, and detecting autoimmune diseases. Common tests described include TSH, free T4, T3, thyroid antibodies, radioactive iodine uptake, TRH stimulation, and thyroid scanning. Abnormalities in thyroid function testing can indicate hypothyroidism or hyperthyroidism. The document outlines causes and clinical features of each, and how to evaluate results based on hormone levels. Fine needle aspiration cytology of the thyroid is also summarized.
This document discusses an approach to a person with an abnormal thyroid stimulating hormone (TSH) level. It begins by introducing the thyroid gland and hormones T4 and T3, which are regulated by TSH. Several conditions can cause high or low TSH, including hypothyroidism, hyperthyroidism, thyroid hormone resistance, and TSH-secreting pituitary adenomas. Specific thyroid conditions discussed in detail include Hashimoto's thyroiditis, iodine deficiency, acute/subacute/silent/chronic thyroiditis, and subclinical hypothyroidism. Treatment depends on the underlying condition but may include levothyroxine, glucocorticoids, surgery, or radiation therapy.
This document summarizes thyroid diseases and evaluation of thyroid nodules. It discusses the peripheral action of thyroid hormones, thyroiditis conditions including Hashimoto's, subacute, and Riedel's, hyperthyroidism including Graves' disease and toxic nodular goiter, evaluation of thyroid nodules including risk factors and initial workup, and treatment options for hyperthyroidism such as antithyroid medications, radioactive iodine, and surgery.
Hypothyroidism is a common endocrine disorder where the thyroid gland produces insufficient hormones. It affects 1.8% of the population and is more prevalent in females and the elderly. The most common cause is Hashimoto's thyroiditis which results in lymphocytic infiltration and thyroid damage. Symptoms of hypothyroidism are non-specific but include fatigue, weight gain, dry skin, and low heart rate. Treatment involves lifelong thyroid hormone replacement therapy with levothyroxine to normalize thyroid levels. Special care is needed in pregnancy, myxedema coma, and avoiding overtreatment.
This document discusses thyroid disorders and their management. It covers the thyroid gland's function of producing hormones that regulate metabolism. It describes hypothyroidism and hyperthyroidism, their clinical presentations, and treatment approaches. It discusses subclinical thyroid disease and when treatment may be indicated. It also covers euthyroid sick syndrome, myxedema coma, thyroid storm, and their treatments.
This document discusses thyroid emergencies including thyroid storm and myxedema coma. It provides details on the synthesis and effects of thyroid hormones, diagnosis of thyroid storm using the Burch-Wartofsky Point Scale and Japan Thyroid Association criteria, and management principles for thyroid storm including beta blockers, antithyroid medications, corticosteroids, iodine, and definitive therapy. Precipitating factors and management of myxedema coma are also summarized.
Hyperthyroidism, also known as overactive thyroid, results from excessive thyroid hormone production and secretion. Graves' disease, the most common cause, is an autoimmune disorder where antibodies stimulate the thyroid. It is characterized by diffuse thyroid enlargement, ophthalmopathy, and pretibial myxedema. Symptoms include palpitations, heat intolerance, weight loss and tremors. Diagnosis involves low TSH and high T4 levels and presence of thyroid autoantibodies. Treatment options include antithyroid medications, radioactive iodine ablation, or surgery. Thyroid storm is a medical emergency characterized by severe hyperthyroid symptoms that requires urgent beta-blockers, antithyroid drugs and supportive
The document discusses thyroid disorders including hyperthyroidism, hypothyroidism, and thyroid storm and their implications for anesthesia such as increased sensitivity to drugs, risks of tachycardia and arrhythmias, and need for careful monitoring of cardiac and respiratory function. It provides guidance on preoperative preparation, intraoperative management, and postoperative care for patients with thyroid disorders undergoing surgery.
This document provides an overview of hypothyroidism, including:
1. It discusses the anatomy and function of the thyroid gland and describes primary causes of hypothyroidism like chronic lymphocytic thyroiditis and iodine deficiency.
2. Laboratory tests for assessing hypothyroidism are outlined, with TSH identified as the most specific indicator. Conditions that can alter TSH and thyroid hormone levels are also noted.
3. The clinical presentation of hypothyroidism is reviewed along with treatment considerations like increased thyroid hormone needs during pregnancy. Biochemical markers and expected signs of clinical improvement with treatment are summarized.
2012 Clinical Practice guidelines for hypothyroidism in adults: American Asso...Jibran Mohsin
This is presentation format of 2012 Clinical Practice guidelines for hypothyroidism in adults: American Association of Clinical Endocrinologists (AACE) / American Thyroid Association (ATA)
Hyperthyroidism is caused by excessive thyroid function and the major causes are Graves' disease, toxic multinodular goiter, and toxic adenomas. Graves' disease accounts for 60-80% of cases and is an autoimmune disorder caused by thyroid stimulating immunoglobulins that activate the TSH receptor. It can cause hyperthyroidism, ophthalmopathy, and dermopathy. Symptoms include weight loss, tremors, palpitations, and goiter. Treatment involves antithyroid medications, radioiodine ablation, or surgery. Thyroiditis can cause temporary hyperthyroidism or hypothyroidism and is usually self-limiting. Pregnancy increases hCG and estrogen
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...rightmanforbloodline
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
2. Objectives
• to discuss the diagnostic criteria for thyroid storm
• to describe the therapeutic options available for
the management of this endocrine emergency
• to discuss updates on the management of thyroid
storm
3. Thyroid Storm
• A life threatening exacerbation of the hyperthyroid
state
• evidence of decompensation in one or more organ
systems
• Rare in literature
• Incidence of <10% among patients hospitalized
for thyroxicosis
4. Thyroid Storm
• Exacerbation of pre existing hyperthyroidism due
to any of the following:
• Graves’ disease
• Toxic multinodular goiter
• Toxic adenomas
• Hypersecretory thyroid carcinoma
5. Epidemiology
• Rare
• Japan (2012): estimated incidence of TS in
hospitalised patients of 0.20 per 100,000 per year
• Mortality rates: 11.0% in TS1 (definite) 9.5% in
TS2 (suspected)
Akamizu et. al Thyroid Volume 2, Number 7, 2012
7. Pathogenesis - 1
• unclear
• are circulating thyroid hormones higher than
usual?
• No difference in thyroid hormone levels between
uncomplicated thyrotoxicosis and thyroid storm
8. Pathogenesis - 2
• Absolute levels not as important as the rapidity
with hormone levels rise
1. change in levels of binding proteins
2. production of thyroid hormone binding inhibitors
3. rapid release of hormones into the blood stream
9. Pathogenesis - 3
• Acute release of thyroid hormones and rapid
change in their concentrations explain many
cases of thyroid storm
• post RAI therapy
• post surgery
• sudden withdrawal of anti-thyroid drugs
10. Pathogenesis - 4
• Development of tissue intolerance of thyroid
hormones
• Activation of the adrenergic nervous system:
increased density of beta-adrenergic receptors
11. Clinical Presentation
• Generally have all the features of thyrotoxicosis
but exaggerated and severe
• Goiter is almost always present
• Usually with a history of thyroid disease that has
been partially treated
• Or history of symptoms of thyrotoxicosis for a
prolonged period
12. Common Essential Findings
• Altered mental status
• TIP#1: if mentation is normal, the diagnosis of thyroid
storm is not likely
• Defective thermoregulation
• TIP#2: this become apparent upon evaluation of
initial therapeutic measures
• A precipitating event or illness is essential to the
genesis of the thyroid storm
13. Precipitants of Thyroid Storm
• INFECTION
• Surgery
• RAI therapy
• Iodinated contrast dyes
• Withdrawal of ATD
• Amiodarone
• Kelp and thyroid
hormone ingestion
• Tooth extraction
• Thyroid Ca
• Diabetic ketoacidosis
• CHF
• Hypoglycemia
• Toxemia of pregnancy
• Parturition
• Severe emotional
stress
• Pulmonary embolism
• CVD
• Trauma
• Bowel obstruction
14. Precipitating Factors
• Acute illness, including infection, stroke, trauma,
surgery and treatment with RAI
• Emotional stress and vigorous palpation of the
thyroid gland have also been reported to
precipitate thyroid storm
15. Japan Survey (2012)
• Irregular use or
discontinuation of drugs - 122
• Infection - 89
• DKA - 12
• Nonthyroidal surgery - 8
• Radioactive iodine - 6
• Pregnancy/delivery - 5
• CVD - 3
• Intense exercise - 2
• Ischemic heart disease - 1
• Adrenocortical insufficiency -
1
• Administration of iodinated
contrast
• Tooth extraction 1
• Others - 1
Akamizu et. al Thyroid Volume 2, Number 7, 2012
16. Question?
• What clinical and laboratory findings are typically
associated with thyroid storm?
• How is it diagnosed?
Diagnosis is made clinically in the background
of thyrotoxicosis
17. Diagnostic Criteria
• Burch and Wartofsky (1993)
• diagnostic point scale (BWS)
• distinguish uncomplicated thyrotoxicosis from
impending and established thyroid storm
• for triage at the ER
18. Diagnostic Criteria for
Thyroid Storm
• Thermoregulatory
dysfunction
• Central nervous
system effects
• Gastrointestinal
hepatic
dysfunction
• Cardiovascular
dysfunction
A. Tachycardia
B. CHF
C. AF
• Precipitant History
Burch HB, Wartofsky L. Endocrinol. Metab Clin 22:23-277
20. Burch and Wartofsky Scoring
System
• Assign points to the highest weighted description
applicable in each category
• Points are given so as to bias the diagnosis of
thyroid storm e.g. when not possible to distinguish
between effects of intercurrent illness and thyroid
storm per se
• Tip#3 When in doubt, treat
21. P.E. at the ER
• BP: 140/70mmHg
• CR: 136 irreg, irreg
• RR: 28 br/min
• Temp: 39.2
• Stuporous
• Icteric sclerae, diffuse goiter 2x enlarged (-) bruit, (+)stare
• (+) Fine crackles at LLLF
• Irregularly irregular rhythm, tachycardic, (-) murmur, AB displaced 6th ICS LAAL
• Scaphoid abdomen, liver edge not palpable
• Grade 2 bipedal edema, +++ DTR’s
22. BW Score for the Case pt
Temp 39.2 20
CNS decrease sensorium 20
GIT jaundice 20
Heart rate 136 20
CHF pedal edema 20
AF (+) RVR 10
Ppt Hx Pneumonia 10
105
23. Japanese Criteria
Grade of TS
Combination of
features
Requirements for diagnosis
TS1 First combination
Thyrotoxicosis and at least one CNS manifestation and
on of the ff: fever, tachycardia, CHF or GI/hepatic
manifestations
TS1
Alternate
combinations
Thyrotoxicosis and at least 3 combinations of fever
tachycardia, CHF or GI/hepatic manifestations
TS2 First combination
Thyrotoxicosis and at least 2 of the ff: fever,
tachycardia, CHF or GI/hepatic manifestations
TS2
Alternate
combination
Patients who meet the diagnostic criteria for TS1 except
that serum FT3 and FT4 values are not available but
whose data before or after the episode suggest that they
are thyrotoxic at the time of TS
Akamizu et. al Thyroid Volume 2, Number 7, 2012
24. Japanese Criteria:
Definitions
• Thyrotoxicosis: Elevated to FT3 and FT4
• CNS manifestations: restlessness, delirium, mental
aberation/psychosis, somnolence/lethargy,
convulsion, coma including a score of 14 or lower
on the Glasgow Coma Scale
• Fever: 38c or higher
• Tachycardia: 130 beats per minute (arrhythmia
such as AF are evaluated my measuring the heart
rate)
Akamizu et. al Thyroid Volume 2, Number 7, 2012
25. Laboratory Findings
• Hyperglycemia, marked leukocytosis, mild
hypercalcemia due to hemoconcentration and
the effect of thyroid hormone on bone
resorption
• Hepatic dysfunction: elevated ALT, LDH and
bilirubins
• Elevated total and free thyroid hormones with
suppressed TSH
26. Treatment Principles
• Correct hyperthyroidism
• Block synthesis of additional hormones
• Block release of preformed hormones
• Inhibit peripheral conversion to T4 to T3
• Measures to decrease circulating hormone levels
• Definitive treatment
• Normal homeostatic decompensation
• Treat precipitating events
27. Drugs Affecting T3-T4
Synthesis
• Block Synthesis:
• Thioamides (PTU, Methimazole, Carbimazole)
• thioamides inhibit peroxidase to block
organification and coupling
• BLOCK RELEASE OF PREFORMED
HORMONES: High dose inorganic iodides reduce
T3-T4 release by inhibiting thyroglobulin
proteolysis
28. Treatment Modalities
1. Block synthesis of hormones
A. Propylthiouracil (PTU) -
• preferred: + inhibits peripheral conversion of T4 to
T3
• LD: 600 to 1000mg -> 200-250mg q4 hrs (1200 -
1500 mg daily dose)
2. Methimazole: LD of 600mg then 20mg q4 hrs (120
mg total daily dose)
29. Agents to block release of
hormones: Inorganic iodides
• Administered only after the inhibition of further
thyroid hormone synthesis has been achieved
with PTU or MMI
• Also inhibit hormone synthesis by blocking iodine
organification (Wolff-Chaikoff effect)
• Iodines + thioamides: T4 may normalize in 4-
5days
30. Agent to block release of
hormones: Inorganic iodides
• Orally by NGT
• Saturated solution of potassium iodide (SSKI), 5
drops q6 hrs
• Lugol’s solution 30 drops in 3-4 doses
• Radiographic contrast dyes e.g. ipodate
(Orografin) and iopanoate (Telepaque)
• Ipodate: 617mg iodine/g - 0.5-3g/day
31. Agent to inhibit peripheral
conversion of T4 to T3
• T4 is a prohormone
• T3 is 3x more potent than T4
• PTU (but not MMI)
• High dose iodides
• Beta-blockers (Propanolol)
• Corticosteroids (dexa 2mg q6 hrs)
32. Measures to decrease
circulating hormone levels
• Plasmapheresis
• Plasma exchange
• Peritoneal dialysis
• Exchange transfusion
• Charcoal plasmaperfusion
Reserved for those patients who fail to respond to the conventional
medical therapy
33. Plasmapheresis
• The half-life of thyroid hormones is so long that
quick improvement is not always achieved even
by sufficient doses of anti-thyroid drugs.
• Thus, plasma exchange in combination with
conventional therapy appears to be effective in
relieving the life threatening thyroid crisis.
35. Homeostatic
Decompensation
• Antiadrenergic agents
• Reserpine and guanethidine
• Propranolol: 20 to 40 mg q6 hours up to 240-
480mg/day
• Esmolol, a short acting B1 selective agent for
thyroid storm, peri-op
36. Homeostatic
Decompensation
• Aggressive treatment of hyperthermia
• Aimed at central thermoregulation centers, as well
as peripheral heat dissipation
• Do not use aspirin
• Peripheral measures: ice packs, cooling blankets,
paracetamol BUT avoid shivering
37. Homeostatic
Decompensation
• Glucocorticoids: given for potential relative adrenal
insufficiency
• Thyrotoxicosis: accelerated production and degradation
of cortisol
• Patient in storm have inappropriately normal cortisol
levels
• Dexamethasone 2mg q6
• Hydrocortisone 100 mg q8
38. Treatment Principles
• Correct hyperthyroidism
• Block synthesis of additional hormones
• Block release of preformed hormones
• Inhibit peripheral conversion of T4 to T3
• Measures to decrease circulating hormone levels
• Definitive treatment
• Normalize homeostatic decompensation
• Treat precipitating events i.e broad spectrum antibiotics
39. Summary
• High dose thioamides: PTU or MMI
• High dose iodides i.e SSKI 2 drops every 6 hrs
• Propranolol (or esmolol): watch the BP
• Control the temperature
• Address the precipitants i.e infection
• Prevent another episode
40. Prognosis
• if appropriate therapeutic measures are
implemented and these measures are successful,
these patient usually improve in 1 to 2 days and
recover within a week
• Mortality rate remains high (10%) even with
prompt and aggressive treatment typically due to
arrhythmia, heart failure or refractory hyperthermia
41. Poor prognostic indicators
• Coma
• Jaundice
• Shock
• Young patients (<40 years): more labile and
variable course and tend to have hyperadrenergic
state
Reserpine irreversibly blocks the vesicular monoamine transporter (VMAT).[6] This normally transports free intracellular norepinephrine, serotonin, and dopamine in the presynaptic nerve terminal into presynaptic vesicles for subsequent release into the synaptic cleft ("exocytosis").
Guanethidine is transported by uptake 1 into the presynaptic terminal transported by norepinephrine transporter (NET). replaces NE in the vesicles